Lataa...
PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS IN THE 21st CENTURY: FOCUS ON RITUXIMAB
Rheumatoid arthritis (RA) is one of the most common and severe chronic inflammatory diseases. The paper reviews the recent studies evaluating the efficacy of rituximab (MabThera®), chimeric anti-CD20 monoclonal antibodies in B cells, in patients with RA. It has been shown that Rituximab is an extrem...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Russo |
| Julkaistu: |
IMA-PRESS LLC
2009-12-01
|
| Sarja: | Современная ревматология |
| Aiheet: | |
| Linkit: | https://mrj.ima-press.net/mrj/article/view/261 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|